MEI Pharma soars after $100 million raise to buy litecoin
** Drug developer MEI Pharma's MEIP.O shares jump 78.4% to $8.09 premarket ** MEIP announces $100 million private placement to initiate litecoin treasury strategy ** Co sold 29.2 million shares at $3.42 apiece in placement led by crypto trading firm GSR and Charlie Lee ** Lee, who founded crypto token litecoin in 2011, will join MEIP's board ** Titan Partners Group, a division of American Capital Partners, was the sole placement agent ** GSR will be MEIP's digital asset and treasury management advisor ** As of last close, MEIP shares up 82.9% YTD (Reporting by Arasu Kannagi Basil in Bengaluru) ((ArasuKannagi.Basil@thomsonreuters.com))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations